154 related articles for article (PubMed ID: 9209522)
1. Clinical significance of p53, nm23, and bcl-2 in T3-4N1M0 oesophageal carcinoma: an immunohistochemical approach.
Patel DD; Bhatavdekar JM; Chikhlikar PR; Patel YV; Shah NG; Ghosh N; Suthar TP; Balar DB
J Surg Oncol; 1997 Jun; 65(2):111-6. PubMed ID: 9209522
[TBL] [Abstract][Full Text] [Related]
2. Immunoexpression of nm23 in advanced esophageal squamous cell carcinoma.
Szumiło J; Skomra D; Chibowski D; Dabrowski A; Wallner G; Maciejewski R
Folia Histochem Cytobiol; 2002; 40(4):377-80. PubMed ID: 12502190
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of nm23-H1 and c-erbB-2 proteins have prognostic significance in adenocarcinoma but not in squamous cell carcinoma of the uterine cervix.
Mandai M; Konishi I; Koshiyama M; Komatsu T; Yamamoto S; Nanbu K; Mori T; Fukumoto M
Cancer; 1995 May; 75(10):2523-9. PubMed ID: 7736397
[TBL] [Abstract][Full Text] [Related]
4. C-erbB-2, p53, and nm23 gene product expression in breast cancer in young women: immunohistochemical analysis and clinicopathologic correlation.
Bertheau P; Steinberg SM; Merino MJ
Hum Pathol; 1998 Apr; 29(4):323-9. PubMed ID: 9563780
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of the nm23 protein in the progression of oesophageal adenocarcinoma.
Sarris M; Konopka M; Lee CS
Pathology; 2003 Feb; 35(1):37-41. PubMed ID: 12701682
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
[TBL] [Abstract][Full Text] [Related]
7. Expression of nm23-H1 gene product in esophageal squamous cell carcinoma and its association with vessel invasion and survival.
Tomita M; Ayabe T; Matsuzaki Y; Edagawa M; Maeda M; Shimizu T; Hara M; Onitsuka T
BMC Cancer; 2001; 1():3. PubMed ID: 11319942
[TBL] [Abstract][Full Text] [Related]
8. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
[TBL] [Abstract][Full Text] [Related]
9. p53, c-erbB-2 and nm23 expression have no prognostic significance in primary pulmonary adenocarcinoma.
MacKinnon M; Kerr KM; King G; Kennedy MM; Cockburn JS; Jeffrey RR
Eur J Cardiothorac Surg; 1997 May; 11(5):838-42. PubMed ID: 9196297
[TBL] [Abstract][Full Text] [Related]
10. [Expressions and their clinical significance of bcl-2 and nm23 in epithelial ovarian carcinoma].
Cao LQ; Chen XM; Li X
Hunan Yi Ke Da Xue Xue Bao; 2000 Apr; 25(2):188-90. PubMed ID: 12212220
[TBL] [Abstract][Full Text] [Related]
11. [The expression of nm23-H1 and p53 protein in nasopharyngeal carcinoma].
Zhou Y; Xu A; Ling X
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1998 Jun; 12(6):243-6. PubMed ID: 11189166
[TBL] [Abstract][Full Text] [Related]
12. [Significance of p53, c-myc and nm23 protein expression in recurrent laryngeal carcinoma].
Guo R; Huang D; Yang W; Han D
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Mar; 17(3):161-3. PubMed ID: 12815897
[TBL] [Abstract][Full Text] [Related]
13. P53, bcl-2, and nm23 expressions in serous ovarian tumors: correlation with the clinical and histopathological parameters.
Arik D; Kulaçoğlu S
Turk Patoloji Derg; 2011 Jan; 27(1):38-45. PubMed ID: 21469425
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.
Lee KE; Lee HJ; Kim YH; Yu HJ; Yang HK; Kim WH; Lee KU; Choe KJ; Kim JP
Jpn J Clin Oncol; 2003 Apr; 33(4):173-9. PubMed ID: 12810831
[TBL] [Abstract][Full Text] [Related]
15. The nature of the cardiac myxoma.
Suvarna SK; Royds JA
Int J Cardiol; 1996 Dec; 57(3):211-6. PubMed ID: 9024908
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical evaluation of nm23-H1 gene product in transitional cell carcinoma of the bladder.
Nakopoulou LL; Constandinides CA; Tzonou A; Lazaris AC; Zervas A; Dimopoulos CA
Histopathology; 1996 May; 28(5):429-35. PubMed ID: 8735718
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein, metallothionein and NM23 protein expressions in breast carcinoma.
Vázquez-Ramírez FJ; González-Cámpora JJ; Hevia-Alvarez E; Fernández-Santos JM; Ríos-Martín JJ; Otal-Salaverri C; González-Cámpora R
Pathol Res Pract; 2000; 196(8):553-9. PubMed ID: 10982018
[TBL] [Abstract][Full Text] [Related]
18. Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53.
Ambros RA; Vigna PA; Figge J; Kallakury BV; Mastrangelo A; Eastman AY; Malfetano J; Figge HL; Ross JS
Cancer; 1994 Mar; 73(6):1686-92. PubMed ID: 8156496
[TBL] [Abstract][Full Text] [Related]
19. nm23 expression in malignant ascitic effusions of serous ovarian adenocarcinoma.
Simone G; Falco G; Caponio MA; Campobasso C; De Frenza M; Petroni S; Wiesel S; Leone A
Int J Oncol; 2001 Nov; 19(5):885-90. PubMed ID: 11604983
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the prognostic significance of nm23/NDP kinase and cathepsin D in anal carcinomas. An immunohistochemical study.
Holm R; Tanum G
Virchows Arch; 1996 May; 428(2):85-9. PubMed ID: 8925129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]